M A Rubin

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi request reprint Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications
    M A Rubin
    Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    Am J Surg Pathol 22:840-8. 1998
  2. ncbi request reprint Morphological features of TMPRSS2-ERG gene fusion prostate cancer
    J M Mosquera
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115 6110, USA
    J Pathol 212:91-101. 2007
  3. doi request reprint TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival
    S Perner
    Department of Pathology and Laboratory Medicine, Weill Cornell Medical Center, New York, NY, USA
    J Pathol 217:65-72. 2009
  4. ncbi request reprint Is microvascular invasion on radical prostatectomy specimens a useful predictor of PSA recurrence for prostate cancer patients?
    A de la Taille
    Department of Urology, Columbia Presbyterian Medical Center, Columbia University School of Public Health, New York, NY 10032, USA
    Eur Urol 38:79-84. 2000
  5. pmc Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
    R Shah
    Department of Pathology, Section of Urology, University of Michigan, Ann Arbor, Michigan, USA
    Am J Pathol 158:1767-73. 2001
  6. ncbi request reprint Prevalence and location of peripheral nerve found on prostate needle biopsy
    M Zhou
    Department of Pathology, University of Michigan, Ann Arbor, USA
    Am J Clin Pathol 115:39-43. 2001
  7. ncbi request reprint Molecular markers for renal cell carcinoma: impact on diagnosis and treatment
    M Zhou
    Department of Pathology, University of Michigan Medical School, Ann Arbor, USA
    Semin Urol Oncol 19:80-7. 2001
  8. pmc Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model
    S Manley
    Department of Pathology, University of Michigan Comprehensive Cancer and Geriatrics Center, Ann Arbor, Michigan 48109-0946, USA
    Am J Pathol 159:837-43. 2001
  9. ncbi request reprint Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading
    G S Bova
    Department of Pathology, Johns Hopkins University, Baltimore, MD 21287-6417, USA
    Hum Pathol 32:417-27. 2001
  10. ncbi request reprint Rapid ("warm") autopsy study for procurement of metastatic prostate cancer
    M A Rubin
    Department of Pathology, University of Michigan, Ann Arbor 48109, USA
    Clin Cancer Res 6:1038-45. 2000

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications
    M A Rubin
    Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    Am J Surg Pathol 22:840-8. 1998
    ..The close association between high tumor volume and HGCP supports the theory that the development of HGCP is a late event in tumor progression, more compatible with the intraductal spread of tumor than dysplasia...
  2. ncbi request reprint Morphological features of TMPRSS2-ERG gene fusion prostate cancer
    J M Mosquera
    Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115 6110, USA
    J Pathol 212:91-101. 2007
    ..These features may also be helpful in diagnosing TMPRSS2-ERG fusion prostate cancer, which may have both prognostic and therapeutic implications...
  3. doi request reprint TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival
    S Perner
    Department of Pathology and Laboratory Medicine, Weill Cornell Medical Center, New York, NY, USA
    J Pathol 217:65-72. 2009
    ..We conclude that TTF1 amplification is a mechanism of high-level TTF1 expression in a subset of NSCLCs. When expressed at high levels, this routinely used diagnostic marker is also an independent biomarker of favourable prognosis in AC...
  4. ncbi request reprint Is microvascular invasion on radical prostatectomy specimens a useful predictor of PSA recurrence for prostate cancer patients?
    A de la Taille
    Department of Urology, Columbia Presbyterian Medical Center, Columbia University School of Public Health, New York, NY 10032, USA
    Eur Urol 38:79-84. 2000
    ..The goal of this study was to investigate the clinical utility of vascular invasion in prostate cancer patients treated by radical prostatectomy as a predictor of PSA recurrence...
  5. pmc Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
    R Shah
    Department of Pathology, Section of Urology, University of Michigan, Ann Arbor, Michigan, USA
    Am J Pathol 158:1767-73. 2001
    ..Gain of 8c is significantly greater in PAH than benign prostate, SA, and even HGPIN. These findings demonstrate a strong association between PAH and PCA, supporting its role as a neoplastic precursor...
  6. ncbi request reprint Prevalence and location of peripheral nerve found on prostate needle biopsy
    M Zhou
    Department of Pathology, University of Michigan, Ann Arbor, USA
    Am J Clin Pathol 115:39-43. 2001
    ..Careful examination of routine H&E-stained specimens is sufficient to detect all important PNI...
  7. ncbi request reprint Molecular markers for renal cell carcinoma: impact on diagnosis and treatment
    M Zhou
    Department of Pathology, University of Michigan Medical School, Ann Arbor, USA
    Semin Urol Oncol 19:80-7. 2001
    ..High-throughput DNA and tissue microarray techniques promise to revolutionize the discovery and validation of novel molecular markers...
  8. pmc Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model
    S Manley
    Department of Pathology, University of Michigan Comprehensive Cancer and Geriatrics Center, Ann Arbor, Michigan 48109-0946, USA
    Am J Pathol 159:837-43. 2001
    ..Because the review is performed over the Internet, this system is ideal for collaborative multi-institutional studies...
  9. ncbi request reprint Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading
    G S Bova
    Department of Pathology, Johns Hopkins University, Baltimore, MD 21287-6417, USA
    Hum Pathol 32:417-27. 2001
    ..hum pathol 32:417-427...
  10. ncbi request reprint Rapid ("warm") autopsy study for procurement of metastatic prostate cancer
    M A Rubin
    Department of Pathology, University of Michigan, Ann Arbor 48109, USA
    Clin Cancer Res 6:1038-45. 2000
    ..The development and expansion of this program represent a valuable resource for molecular and clinical researchers...
  11. ncbi request reprint Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy
    M Zhou
    Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA
    J Urol 166:2193-7. 2001
    ..Nuclear morphology is subject to tissue fixation and processing artifact. Any nuclear morphometric study must consider this artifact...
  12. ncbi request reprint TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
    F Demichelis
    Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115 6110, USA
    Oncogene 26:4596-9. 2007
    ..005). These data suggest that TMPRSS2:ERG fusion prostate cancers may have a more aggressive phenotype, possibly mediated through increased ERG expression...
  13. ncbi request reprint [Cytogenetic alterations in renal tumors. Applications for comparative genomic hybridization and fluorescence in situ hybridization]
    K D Mertz
    Department of Pathology, Brigham and Women s Hospital, Boston, MA, USA
    Urologe A 45:316-8, 320-2. 2006
    ..2;q21.2) translocation. Although not required for most clinical diagnoses, CGH and FISH complement the standard histologic diagnosis of RCC and may provide a definitive diagnosis in a small number of challenging cases...
  14. ncbi request reprint Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer
    M A Rubin
    Department of Pathology, Urology, and the Comprehensive Cancer and Geriatrics Center of the University of Michigan, Ann Arbor, MI 48109, USA
    J Pathol 195:80-6. 2001
    ..This review will concentrate on the application of laser capture microdissection, cDNA microarrays, and tissue microarrays in the area of prostate cancer research...
  15. ncbi request reprint Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis
    M A Ficazzola
    Department of Urology, New York University School of Medicine, 540 First Avenue, New York, NY 10016, USA
    Carcinogenesis 22:1271-9. 2001
    ..Furthermore, these findings suggest that a significant component of the p53 G(1) arrest pathway might be inactivated in prostate cancer even in the absence of genetic mutations in p53...
  16. pmc Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis
    M A Rubin
    Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA
    Am J Pathol 159:1211-8. 2001
    ....
  17. ncbi request reprint Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men
    K L Nastiuk
    Department of Pathology and Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Prostate 40:172-7. 1999
    ..We aimed to determine whether the common germline mutations of BRCA1 or BRCA2 in Ashkenazi Jewish men predisposed them to prostate cancer...
  18. ncbi request reprint Delineation of prognostic biomarkers in prostate cancer
    S M Dhanasekaran
    Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
    Nature 412:822-6. 2001
    ..Thus, the integration of cDNA microarray, high-density tissue microarray, and linked clinical and pathology data is a powerful approach to molecular profiling of human cancer...